Sign in
Taking people in United StatesNo phase

Compares 2-week and 6-week home blood pressure monitoring after childbirth

Tests how long home blood pressure monitoring lasts after delivery in women with pregnancy hypertension.

Key facts

Who runs it
University of Minnesota
Where
Minneapolis, United StatesSee the site
Trial code
Registry title
HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring
Status
Recruiting
People taking part
400 people, planned
Started
7 Jan 2026
Expected to end
31 Jan 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • 2-Week Home Monitoring
  • 6-Week Home Monitoring
Record updated
14 January 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women aged 18 or older who had a hypertensive disorder of pregnancy, gave birth at University of Minnesota Medical Center, and joined the HOPE-BP Program for blood pressure monitoring at home after delivery.

Age
18 years or older
Sex
Female
Disease stage
Hypertensive disorder of pregnancy; the person has gone home after delivery.
Earlier treatment
Must not still be taking blood pressure medicine at 2 weeks after delivery (time of randomization).

Main reasons for not taking part

  • Still taking blood pressure medicine at 2 weeks (time of randomization)
  • A medical condition that makes it not clinically appropriate to randomize
  • Opted out of clinical research

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • 18 years or older
  • Discharged after delivery at University of Minnesota Medical Center
  • Enrolled into the HOPE-BP Program

Who cannot take part

  • Ongoing antihypertensive medication use at 2 weeks (time of randomization)
  • Have a medical comorbidity that would not be clinically appropriate to randomize
  • Patients opted out of clinical research

Where in United States

  • University of MinnesotaMinneapolis, United StatesContact: Erin LindenTaking people

About the trial

What the trial wants to find out

Postpartum remote blood pressure monitoring programs for patients with hypertensive disorders of pregnancy (HDP) are becoming part of standard postpartum management. Existing programs range in duration from 2 to 6 weeks but there has not been any evaluation as to what program duration is optimal. The primary objective of this study is to evaluate the impact of program duration on clinical outcomes for patients participating in a single institution's postpartum remote blood pressure monitoring program for patients with HDP.

The 2 groups in the trial

  • 2-Week ArmExisting treatment, for comparison

    Participants randomized into the 2 week arm will be immediately unenrolled from the postpartum remote blood pressure monitoring program and resume standard postpartum care

    Treatment: 2-Week Home Monitoring

  • 6-Week ArmExisting treatment, for comparison

    Patients randomized into the 6 week arm will continue and complete the program in its entirety per current SOC (4 additional weeks)

    Treatment: 6-Week Home Monitoring

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring
Plain-language title
Compares 2-week and 6-week home blood pressure monitoring after childbirthGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
14 January 2026